Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (891-900 of 903) with videos related to

Pageof 91
Sort By:
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Acta Neuropathologica|January 20, 2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Acta Neuropathologica|May 28, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
JAMA|May 20, 2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisWillemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypesYann Le Guen, Guo Luo, Aditya Ambati, et al.
Acta Neuropathologica|September 6, 2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkersIris E Jansen, Sven J van der Lee, Duber Gomez-Fonseca, et al.
Molecular Psychiatry|December 5, 2024
X-chromosome-wide association study for Alzheimer's diseaseJulie Le Borgne, Lissette Gomez, Sami Heikkinen, et al.
The Lancet. Neurology|June 20, 2014
Frontotemporal dementia and its subtypes: a genome-wide association studyRaffaele Ferrari, Dena G Hernandez, Michael A Nalls, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Pageof 91

Showing results (891-900 of 903) with videos related to

Sort By:
Pageof 91
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Acta Neuropathologica|January 20, 2020
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
Acta Neuropathologica|May 28, 2019
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J van der Lee, Olivia J Conway, Iris Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
JAMA|May 20, 2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisWillemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2023
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by <i>HLA-DRB1*04</i> subtypesYann Le Guen, Guo Luo, Aditya Ambati, et al.
Acta Neuropathologica|September 6, 2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkersIris E Jansen, Sven J van der Lee, Duber Gomez-Fonseca, et al.
Molecular Psychiatry|December 5, 2024
X-chromosome-wide association study for Alzheimer's diseaseJulie Le Borgne, Lissette Gomez, Sami Heikkinen, et al.
The Lancet. Neurology|June 20, 2014
Frontotemporal dementia and its subtypes: a genome-wide association studyRaffaele Ferrari, Dena G Hernandez, Michael A Nalls, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Pageof 91